ꢀ
Z. Rafinski et al. / Tetrahedron 70 (2014) 5739e5745
5744
solid. The crude material was suspended in ethyl acetate (22 mL)
and stirred vigorously at reflux for 30 min causing a light yellow
precipitate to form. The suspension was allowed to cool to ambient
temperature with vigorous stirring and immersed in an ice/water
bath at 0 ꢂC. The precipitate was collected by suction filtration and
A flame-dried 50 mL round-bottomed flask was charged with
morpholinone (1.0 g, 4.5 mmol) and dichloromethane (22 mL). Tri-
methyloxonium tetrafluoroborate (0.67 g, 4.5 mmol, 1.0 equiv) was
added and stirred under atmosphere of Ar for 6 h. The corresponding
aryl hydrazine was added (4.5 mmol,1 equiv) and stirred at ambient
temperature until the starting material was consumed as visualized
by TLC (ca. 6 h). The solvent was evaporated and the triethyl ortho-
formate (40 equiv) was added. The mixture was then heated to 110 ꢂC
and stirred at this temperature for 18 h. After completion, the solvent
was removed in vacuo. The crude product was washed with AcOEt
affording the pure salt as a white or ochre powder.
washed with EtOAc (3ꢁ5 mL) affording the title compound (1.4 g,
22
yield 84%) as a white powder. Mp¼206e208 ꢂC, yield 84%. [
a]
D
ꢀ8.3 (c 1.1, CH3OH). 1H NMR (400 MHz, DMSO-d6)
d 0.86 (s, 3H;
CH3), 0.88 (s, 3H; CH3), 0.96 (s, 3H; CH3), 1.08e115 (m, 1H),
1.24e1.30 (m, 1H), 1.48e1.61 (m, 2H), 1.43 (dt, J¼5.6, 13.2 Hz, 1H),
1.70e1.76 (m, 1H),1.83 (t, J¼4.0 Hz,1H), 2.19 (s, 6H; 2ꢁ CH3), 2.34 (s,
3H; CH3), 3.17 (dd, J¼5.6, 13.2 Hz, 1H), 3.50 (d, J¼13.2 Hz, 1H), 6.86
(s, 2H; 2ꢁ CHAr), 6.89 (s, 1H), 6.98 (s, 1H), 9.6 (br s, 1H, NH), 10.24 (d,
J¼4.4 Hz, 1H; NH), 11.11 (br s, 1H; NH). 13C NMR (100 MHz, DMSO-
4.3.1. (10R,20R,40R)-10,70,70-Trimethyl-2-phenyl-5,8-dihydrospiro
[[1,2,4]-triazolo[3,4-c][1,4]-oxazine-6,20-bicyclo[2.2.1]heptan]-2-ium
22
d6)
d
10.6 (CH3), 18.3 (2ꢁ CH3), 20.6 (CH3), 20.7 (CH3) 21.3 (CH3),
tetrafluoroborate (A). White solid, mp¼255e256 ꢂC, yield 77%. [
a]
D
26.7 (CH2), 29.5 (CH2), 38.6 (CH2), 45.1 (CH), 46.6 (CH2), 49.2 (C),
ꢀ78.0 (c 1.0, CHCl3).1H NMR (700 MHz, DMSO-d6)
d 0.91 (s, 3H; CH3),
52.3 (C), 55.8 (CH2), 81.7 (C), 129.9 (2ꢁ CHAr), 131.3 (2ꢁ C), 134.1 (C),
0.97 (s, 3H; CH3), 1.03 (s, 3H; CH3), 1.16e1.22 (m, 1H), 1.34e1.39 (m,
2H), 1.53e1.59 (ddd, J¼5.6, 11.9, 14.0 Hz, 1H), 1.75e1.82 (m, 1H), 1.88
(t, J¼4.2 Hz, 1H), 2.30e2.36 (m, 1H), 4.33 (s, 2H; CH2), 5.24 (d,
J¼17.5 Hz, 1H), 5.28 (d, J¼17.5 Hz, 1H), 7.65e7.75 (m, 3H), 7.90e7.94
(cmꢀ1): 3205, 2959, 1726, 1684, 1483,
~
n
138.9 (C), 160.1 (C). IR (ATR)
1339, 1120, 1089, 1045, 850, 762. LRMS (ESI): m/z calcd for
C
C
22H34N3O [MꢀCl]þ, 356.3; found, 356.3. Anal. Calcd for
22H34ClN3O (391.98): C, 67.41; H, 8.74; N,10.72. Found: C, 68.79; H,
(m, 2H),10.80 (s,1H; CH).13C NMR (176 MHz, DMSO-d6)
d 10.5 (CH3),
8.11; N, 10.37%.
20.6 (CH3), 21.2 (CH3), 26.5 (CH2), 29.7 (CH2), 36.2 (CH2), 45.1 (CH),
49.3 (C), 51.4 (CH2), 52.7 (C), 54.5 (CH2), 81.4 (CH), 121.1 (2ꢁ CHAr),
130.8 (2ꢁ CHAr), 131.1 (CHAr), 135.4 (CAr), 142.5 (CH), 149.6 (C). IR
~
521. LRMS (ESI): m/z calcd for C20H26N3O [MꢀBF4]þ, 324.2; found,
324.2. Anal. Calcd for C20H26BF4N3O (411.24): C, 58.41; H, 6.37; N,
10.22. Found: C, 58.46; H, 6.28; N, 10.33%.
4.2.7. (10R,20R,40R)-2-Mesityl-10,70,70-trimethyl-5,8-dihydrospiro
[[1,2,4]-triazolo[3,4-c][1,4] oxazine-6,20-bicyclo[2.2.1]heptan]-2-ium
chloride (D). An oven-dried 50 mL round-bottomed flask was
charged with a magnetic stir bar, 7 (1.2 g, 3.14 mmol), triethyl
orthoformate (5.2 mL, 31.4 mmol, 10 equiv), chlorobenzene (15 mL)
and anhydrous HCl (4 M in 1,4-dioxane, 0.78 mL, 3.14 mmol). The
suspension was stirred at 120 ꢂC for 2 h. The tan-coloured solution
was allowed to cool to ambient temperature, and concentrated
under reduced pressure to afford a crude brown foam. Re-
crystallization from diethyl ether afforded the title compound
(ATR)
n
(cmꢀ1): 2942, 1589, 1438, 1226, 1084, 1048, 979, 761, 686,
4.3.2. (10R,20R,40R)-10,70,70-Trimethyl-2-(perfluorophenyl)-5,8-
dihydrospiro-[[1,2,4]triazolo[3,4-c][1,4]oxazine-6,20-bicyclo[2.2.1]
heptan]-2-ium tetrafluoroborate (B). White solid, mp¼250e252 ꢂC,
yield 72%. [
a
]
22 ꢀ50.0 (c 1.0, acetone). 1H NMR (400 MHz, acetone-
D
(1.0 g, 79%) as a white solid. Mp¼260e262 ꢂC, yield 79%. [
a
]
22 ꢀ45.5
d6)
d
0.96 (s, 3H; CH3), 1.02 (s, 3H; CH3), 1.09 (s, 3H; CH3), 1.25e1.32
D
(c 1.0, CHCl3). 1H NMR (700 MHz, CDCl3)
d
0.92 (s, 3H; CH3), 0.97 (s,
(m, 1H), 1.46e1.53 (m, 1H), 1.56 (d, J¼13.2 Hz, 1H), 1.60e1.68 (m,
1H), 1.79e1.88 (m, 1H), 1.94 (t, J¼4.4 Hz, 1H), 2.45e2.52 (m, 1H),
4.63 (d, J¼13.2 Hz, 1H), 4.86 (d, J¼13.2 Hz, 1H), 5.33 (d, J¼17.6 Hz,
1H), 5.40 (d, J¼17.6 Hz, 1H), 10.45 (s, 1H). 13C NMR (100 MHz, ace-
3H; CH3), 1.04 (s, 3H; CH3), 1.33 (d, J¼12.6 Hz, 1H), 1.40e1.45 (m,
1H), 1.48e1.61 (m, 3H), 1.91 (t, J¼4.2 Hz, 1H), 2.08 (s, 6H; 2ꢁ CH3),
2.20e2.25 (m, 1H), 2.34 (s, 3H; CH3), 4.33 (d, J¼12.6 Hz, 1H), 5.00 (d,
J¼17.5 Hz, 1H), 5.06 (d, J¼17.5 Hz, 1H), 5.33 (d, J¼12.6 Hz, 1H), 6.99
tone-d6)
d 9.4 (CH3), 19.6 (CH3), 20.3 (CH3), 25.9 (CH2), 29.4 (CH2),
(s, 2H; 2ꢁ CHAr), 11.97 (s, 1H; CH). 13C NMR (176 MHz, CDCl3)
d
10.2
36.1 (CH2), 45.4 (CH), 46.8 (C), 52.3 (CH2), 52.7 (C), 54.3 (CH2), 81.5
(cmꢀ1): 2930, 1595, 1522, 1438,
~
n
(CH3), 17.7 (2ꢁ CH3), 20.2 (CH3), 20.7 (CH3), 21.2 (CH3), 26.2 (CH2),
29.8 (CH2), 35.9 (CH2), 45.3 (CH), 49.4 (C), 52.5 (CH2), 52.8 (C), 54.5
(CH2), 82.2 (C), 129.8 (2ꢁ CHAr), 131.2 (C) 134.7 (C), 142.1 (C), 145.5
~
(C), 147.2 (CH), 151.1 (C). IR (ATR)
1075, 1051, 1020, 999, 857, 626, 522. LRMS (ESI): m/z calcd for
C
C
20H21F5N3O [MꢀBF4]þ, 414.2; found, 414.2. Anal. Calcd for
(CH), 145.8 (d, J¼26.4 Hz, CH), 149.3 (C). IR (ATR)
n
(cmꢀ1): 3333,
20H21BF9N3O (501.20): C, 47.93; H, 4.22; N, 8.38. Found: C, 47.81;
2941, 1585, 1448, 1390, 1122, 1082, 976, 846, 580. LRMS (ESI): m/z
calcd for C23H32N3O [MꢀCl]þ, 366.3; found, 366.3. Anal. Calcd for
H, 4.16; N, 8.45%. X-ray crystal structure: C20H21BF9N3O, Mr¼501.20.
Colourless 0.27ꢁ0.16ꢁ0.07 mm crystal obtained from the metha-
C
23H32ClN3O (401.97): C, 68.72; H, 8.02; N, 10.45. Found: C, 68.79;
nol, monoclinic space group P2(1). Cell parameters: a¼10.001(2),
¼96.62(3)ꢂ, V¼1098.9(4) A3,
ꢁ
H, 8.11; N, 10.37%. X-ray crystal structure:
C
23H33ClN3O1.5
,
b¼7.501(2), c¼14.747(3) A,
b
Mr¼410.97. Colourless 0.47ꢁ0.32ꢁ0.26 mm crystal obtained from
Dcalcd¼1.515 mg/m3, Z¼2, F(000)¼512,
m
¼0.146 mmꢀ1. The maxi-
the methanol, triclinic space group P1. Cell parameters:
mum and minimum transmissions of 0.9893 and 0.9606.
ꢁ
a¼12.7769(4), b¼13.5683(4), c¼13.8845(5) A,
a
¼97.978(3),
R1¼0.0533, wR2¼0.1150 for reflections I>2
s(I). The absolute
b
¼93.633(3),
g
¼106.138(3)ꢂ, V¼2276.62(13) A3, Dcalcd¼1.199 mg/
structure Flack parameter x¼0.01(11). The structural data have
been deposited at the Cambridge Crystallographic Data Centre:
(CCDC No. 988374).
m3, Z¼4, F(000)¼884,
m
¼0.188 mmꢀ1. The maximum and minimum
transmissions of 0.9534 and 0.9161. R1¼0.0754, wR2¼0.2097 for
reflections I>2s(I). The absolute structure Flack parameter
x¼0.00(9). The structural data have been deposited at the Cam-
4.3.3. (10R,20R,40R)-10,70,70-Trimethyl-2-(4-nitrophenyl)-5,8-
dihydrospiro-[[1,2,4]triazolo[3,4-c][1,4]oxazine-6,20-bicyclo[2.2.1]
heptan]-2-ium tetrafluoroborate (C). Ochre solid, mp¼316e317 ꢂC,
bridge Crystallographic Data Centre: (CCDC No. 988376).
yield 54%. [
d6)
a
]
22 ꢀ76.6 (c 1.0, acetone). 1H NMR (700 MHz, acetone-
4.3. Preparation of (1R)-camphor-derived triazolium salts AeC
D
d
0.92 (s, 3H; CH3), 0.99 (s, 3H; CH3), 1.05 (s, 3H; CH3), 1.24 (ddd,
J¼4.9, 9.1, 12.6 Hz, 1H), 1.46 (m, 1H), 1.47 (d, J¼13.3 Hz, 1H), 1.60
(ddd, J¼4.9, 11.2, 14.0 Hz, 1H), 1.78e1.83 (m, 1H), 1.89 (t, J¼4.9 Hz,
1H), 2.44 (dt, J¼2.8, 14.0 Hz, 1H), 4.52 (d, J¼12.6 Hz, 1H), 4.70 (d,
J¼12.6 Hz, 1H), 5.30 (d, J¼17.5 Hz, 1H), 5.34 (d, J¼17.5 Hz, 1H),
8.24e8.27 (m, 2H), 8.53e8.56 (m, 2H), 10.67 (s, 1H). 13C NMR
(176 MHz, acetone-d6) d 9.5 (CH3),19.7 (CH3), 20.3 (CH3), 25.9 (CH2),